"Japanese pharmaceutical companies are increasingly looking outside of their country's borders for biotech deals, widening their global presence. These companies look to Western biotechs for cutting-edge technology to fill their pipelines, in turn giving their partners a pathway into Asian markets as well as increased deal dollars. In this session, listen to representatives of Western and Japanese companies that have struck deals discuss the practical and funding advantages of working with a Japanese partner, the Japanese business model, funding and deal-making strategy, and cultural considerations."

Objective1: Offer unique considerations for Japanese company partnerships.

Objective2: Provide specific and experiential information on the unique advantages and challenges of working effectively within Western-Japanese collaborations, important cultural considerations and deal-making goals and strategies.

Objective3: "Provide a better understanding of what Japanese pharmaceutical companies are looking for, what they have to offer, the best ways of working with these companies and
strategies for securing deals."